Verition Fund Management
CRBP icon

Verition Fund Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Verition Fund Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,485
Closed -$119K – 3667
2025
Q1 		$119K Buy
+22,485
New +$198K ﹤0.01% 3139
2024
Q3 		– Sell
-72,842
Closed -$3.3M – 3240
2024
Q2 		$3.3M Buy
+72,842
New +$3.06M 0.02% 982
2022
Q4 		– Sell
-2,202
Closed -$11K – 2251
2022
Q3 		$11K Hold
2,202
– – ﹤0.01% 2854
2022
Q2 		$17K Buy
+2,202
New +$21.3K ﹤0.01% 2227
2017
Q2 		– Sell
-436
Closed -$108K – 978
2017
Q1 		$108K Buy
+436
New +$107K 0.01% 1099

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Verition Fund Management's CRBP Position: Q2 2025 in Review

Verition Fund Management sold out of Corbus Pharmaceuticals (CRBP) in Q2 2025, closing a stake of 22,485 shares — an estimated $119K sold.

Verition Fund Management first reported a position in CRBP in Q1 2017 and held it in 5 quarters. The position peaked at $3.3M in Q2 2024. 80 funds tracked by Wall St. Rank hold CRBP as of Q2 2025.

  • Verition Fund Management reported no remaining Corbus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 22,485 Corbus Pharmaceuticals shares in Q2 2025, an estimated $119K.
  • Verition Fund Management first reported a position in Corbus Pharmaceuticals in Q1 2017 and held it in 5 quarters.
  • Verition Fund Management's Corbus Pharmaceuticals position peaked at $3.3M in Q2 2024.
  • 80 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.